Peer-influenced content. Sources you trust. No registration required. This is HCN.
Conexiant
“Hidradenitis suppurativa (HS) affects far more than skin; it impacts confidence, emotional well-being and relationships during a formative period for many pediatric patients.” – Brindley Brooks, Founder & CEO, HS Connect.
Dermatology March 26th 2026
Medical Professionals Reference (MPR)
The approval was based on data from the randomized, double-blinded, parallel-group phase 3b STEP UP trial, which enrolled 1407 adults aged 18 years and older with a body mass index of at least 30kg/m2, without diabetes.
Endocrinology, Diabetes, Metabolism March 26th 2026
Ophthalmology Management
Reproxalap is an investigational drug candidate for the treatment of dry eye disease.
Ophthalmology March 24th 2026
TECNIS PureSee IOL is the first and only US FDA‑approved extended depth of focus (EDOF) IOL with no warning on loss of contrast sensitivity
MDLinx
“There are a lot of people with autism who don’t have a folate deficiency, and there are a lot of people with a folate deficiency who don’t have autism.” — Ben Rein, PhD
Neurology March 18th 2026
Cardiology Advisor
The Wegovy tablet is the first oral GLP-1 receptor agonist indicated for weight loss and cardiovascular risk reduction in eligible adults.
Endocrinology & Diabetes Nursing March 13th 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS